3653 results for «263»
3653 results
Multi-device approach to calcified lesions
20 May 2026 – From EuroPCR 2026
Explore a multi-device strategy for tackling complex calcified coronary lesions in this session. It includes case studies on left main trifurcation stenting, resistant calcified nodules treated with orbital atherectomy, severe restenosis, and critical calcifications in challenging anatomies, showcasing advanced techniques for plaque modification and lesion management.
When transfemoral is not an option: is TAVI still possible?
20 May 2026 – From EuroPCR 2026
This session explores alternative access strategies for Transcatheter Aortic Valve Implantation (TAVI) when the transfemoral route is not feasible. It covers complex scenarios including transcaval TAVI complications, transaxillary approaches, management of extra-large annuli with peripheral artery disease, and innovative transcarotid valve-in-valve procedures.
Primary PCI dilemmas: when imaging saves the day
21 May 2026 – From EuroPCR 2026
This session highlights the pivotal role of imaging in resolving dilemmas during primary percutaneous coronary intervention (PCI). It presents complex cases illustrating challenges such as coronary compression, thrombus burden in large vessels, and culprit lesion identification, including the use of high-definition intravascular ultrasound (HD-IVUS) to reclassify...
Other right-sided and tricuspid valve interventions
20 May 2026 – From EuroPCR 2026
This session focuses on right-sided heart valve interventions, particularly targeting tricuspid valve disease. Topics include clinical outcomes in atrial functional tricuspid regurgitation, management in the context of left-sided valvular disease, treatment approaches for tricuspid valve endocarditis, and advances in transcatheter therapies and device placements.
Imaging and physiology integration to guided PCI
20 May 2026 – From EuroPCR 2026
Discover the integration of imaging and physiological assessment in guiding percutaneous coronary intervention (PCI). This session highlights the use of multimodality diagnostics, including invasive and non-invasive techniques, to improve planning, strategy, and management of complex coronary lesions.
Complication one: PCI complications occuring during urgent PCI for NSTEMI
20 May 2026 – From EuroPCR 2026
Examine real-world PCI complications encountered during urgent interventions for NSTEMI patients. This session presents a series of complex cases illustrating management strategies for adverse events such as coronary perforations, device issues, and imaging challenges to inform safer procedural practice.
Fighting intracardiac masses
21 May 2026 – From EuroPCR 2026
This session focuses on the percutaneous management of intracardiac masses, presenting innovative approaches such as angiovac-assisted vegetation removal, management of mechanical mitral valve complications, and treatment options for right ventricular tumors. It also evaluates the emerging role of percutaneous therapies in infective endocarditis involving TAVI valves...
Complex patients with NSTEMI
20 May 2026 – From EuroPCR 2026
This session addresses the complexity of managing NSTEMI patients with challenging clinical presentations, including concurrent vessel and valve disease, thrombus burden, and atypical angiographic findings. It offers practical strategies for diagnosis and intervention to optimize patient outcomes.
Imaging-guided calcified lesion PCI
21 May 2026 – From EuroPCR 2026
This session presents state-of-the-art imaging-guided interventions for calcified coronary lesions, showcasing modalities such as lithotripsy, rotational atherectomy, and complex calcium modification techniques. It includes case studies highlighting zero-contrast PCI and stenting in challenging anatomies, including left main bifurcation lesions in elderly patients with complex clinical backgrounds.
SENIOR-RITA - Older patients with non-ST segment elevation myocardial infarction randomised interventional treatment trial
02 Sep 2024
Mirvat Alasnag provides her take on the SENIOR-RITA trial, presented by Vijay Kunadian at the ESC Congress 2024 in London.
Author
EuroPCR 2024: Primary outcomes from PINNACLE I clinical trial establish safety and effectiveness of Elixir Medical’s Hertz Contact Intravascular Lithotripsy System for calcium fragmentation in moderate to severe calcified coronary artery lesions
16 May 2024
Drug-coated balloon (DCB) technology: A pioneer’s view of the historical evolution and future directions
08 Jan 2025
In this article, Bruno Scheller explores advances in local drug delivery, from drug-coated balloons to novel antiproliferative agents. These innovations aim to reduce restenosis, minimize permanent implants, and pave the way for patient-specific coronary artery disease treatments.
Author
Intravascular ultrasound-guided versus angiography-guided percutaneous coronary intervention in acute coronary syndromes: The multicenter, randomized, blinded, IVUS-ACS Trial
09 Apr 2024
Marco Spagnolo and Daniele Giacoppo report the main results of the IVUS-ACS trial presented by Shao-Liang Chen, from the Nanjing First Hospital, Nanjing Medical University, Nanjing, in a Featured Clinical Research session at ACC.24 in Atlanta and simultaneously published in The Lancet.(1)
Author
Author
